germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
Planas R.<br />
Tratami<strong>en</strong>to antiviral y la cirrosis por el virus <strong>de</strong> la hepatitis B y C.<br />
CLIN GASTROENTEROL HEPATOL 2006;6:5‐7<br />
Plauth M, Cabre E, Riggio O, Assis‐Camilo M, Pirlich M, Kondrup J, Fer<strong>en</strong>ci P, Holm E, vom Dahl S, Muller MJ, Nolte W.<br />
ESPEN gui<strong>de</strong>lines on <strong>en</strong>teral nutrition: Liver disease.<br />
CLIN NUTR 2006; 25(2):285‐294.<br />
2,474<br />
Rodrigo Jover, Pedro Zapater, Antoni Castells, Xavier Llor, Virginia Piñol, Montserrat Andreu, Artemio Payá, Cristina Al<strong>en</strong>da, Rosa M.<br />
Xicola, Joaquín Cubiella, Juan D. Morillas, Xavier Bessa, Juan Clof<strong>en</strong>t, Luís Bujanda, Josep M. Reñé, Enrique Quintero.<br />
Mismatch repair status in the prediction of b<strong>en</strong>efit from adjuvant fluorouracil chemotherapy in colorectal cancer. A prospective study.<br />
GUT 2006 Jun;55(6):848‐55<br />
9,002<br />
Rodriguez‐Moranta F, Castells A, Andreu M, Pinol V, Castellvi‐Bel S, Al<strong>en</strong>da C, Llor X, Xicola RM, Jover R, Paya A, Bessa X, Balaguer F,<br />
Cubiella J, Arguello L, Morillas JD, Bujanda L.<br />
Clinical performance of original and revised Bethesda gui<strong>de</strong>lines for the id<strong>en</strong>tification of MSH2/MLH1 g<strong>en</strong>e carriers in pati<strong>en</strong>ts with newly<br />
diagnosed colorectal cancer: Proposal of a new and simpler set of recomm<strong>en</strong>dations.<br />
AM J GASTROENTEROL 2006; 101(5):1104‐1111.<br />
5,608<br />
Sanchez <strong>de</strong> Medina F, Martínez‐Augustin O, Montero T, Suarez MD, Vieites JM, Zarzuelo A, Gassull M.A, Llor X, Suarez A.<br />
Effects of sulfasalazine on g<strong>en</strong>e expression profile in trinitrob<strong>en</strong>z<strong>en</strong>esulfonic acid‐induced rat colitis.<br />
Submitted for publication. 2006<br />
Sanchez‐Tapias JM, Diago M, Escartin P, Enriquez J, Romero‐Gomez M, Barc<strong>en</strong>a R, Crespo J, Andra<strong>de</strong> R, Martinez‐Bauer E, Perez R,<br />
Testillano M, Planas R, Sola R, Garcia‐B<strong>en</strong>goechea M, Garcia‐Samaniego J, Munoz‐Sanchez M, Mor<strong>en</strong>o‐Otero R.<br />
Peginterferon‐alfa2a plus ribavirin for 48 versus 72 weeks in pati<strong>en</strong>ts with <strong>de</strong>tectable hepatitis C virus RNA at week 4 of treatm<strong>en</strong>t.<br />
Gastro<strong>en</strong>terology 2006; 131(2):451‐460.<br />
12,457<br />
Schrier RW, Gross P, Gheorghia<strong>de</strong> M, Berl T, Verbalis JG, Czerwiec FS, and Orlandi C, for the SALT Investigators (Planas R, Hospital<br />
Germans Trias i Pujol).<br />
Tolvaptan, a selective oral vasopressin v2‐receptor antagonist, for hyponatremia.<br />
NEW ENGL J MED 2006;355:2099‐2112<br />
51,296<br />
Sola R, Alvarez MA, Balleste B, Montoliu S, Rivera M, Miquel M, Cirera I, Morillas RM, Coll S, Planas R.<br />
Pàgina 104/177
Change language